143 related articles for article (PubMed ID: 11096114)
21. Structural insights into the human and avian IMP cyclohydrolase mechanism via crystal structures with the bound XMP inhibitor.
Wolan DW; Cheong CG; Greasley SE; Wilson IA
Biochemistry; 2004 Feb; 43(5):1171-83. PubMed ID: 14756553
[TBL] [Abstract][Full Text] [Related]
22. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
23. AICAR transformylase/IMP cyclohydrolase (ATIC) is essential for de novo purine biosynthesis and infection by Cryptococcus neoformans.
Wizrah MSI; Chua SMH; Luo Z; Manik MK; Pan M; Whyte JML; Robertson AAB; Kappler U; Kobe B; Fraser JA
J Biol Chem; 2022 Oct; 298(10):102453. PubMed ID: 36063996
[TBL] [Abstract][Full Text] [Related]
24. The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
Blood; 2009 Mar; 113(12):2776-90. PubMed ID: 18845790
[TBL] [Abstract][Full Text] [Related]
25. Case report of a rare purine synthesis disorder due to 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICAR) deficiency.
Joy P; Madhuri V; Palocaren T; Das S; Susan Cleave Abraham S; Korula S; Koshy B; Jose J; Chandran M; Danda S
Brain Dev; 2022 Oct; 44(9):645-649. PubMed ID: 35637059
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of AICAR transformylase IMP cyclohydrolase (TM1249) from Thermotoga maritima at 1.88 A resolution.
Axelrod HL; McMullan D; Krishna SS; Miller MD; Elsliger MA; Abdubek P; Ambing E; Astakhova T; Carlton D; Chiu HJ; Clayton T; Duan L; Feuerhelm J; Grzechnik SK; Hale J; Han GW; Haugen J; Jaroszewski L; Jin KK; Klock HE; Knuth MW; Koesema E; Morse AT; Nigoghossian E; Okach L; Oommachen S; Paulsen J; Quijano K; Reyes R; Rife CL; van den Bedem H; Weekes D; White A; Wolf G; Xu Q; Hodgson KO; Wooley J; Deacon AM; Godzik A; Lesley SA; Wilson IA
Proteins; 2008 May; 71(2):1042-9. PubMed ID: 18260100
[No Abstract] [Full Text] [Related]
27. Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk.
Gellekink H; Blom HJ; den Heijer M
Clin Chem Lab Med; 2007; 45(4):471-6. PubMed ID: 17439323
[TBL] [Abstract][Full Text] [Related]
28. Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors.
Li C; Xu L; Wolan DW; Wilson IA; Olson AJ
J Med Chem; 2004 Dec; 47(27):6681-90. PubMed ID: 15615517
[TBL] [Abstract][Full Text] [Related]
29. 5-Aminoimidazole-4-carboxamide ribotide transformylase-IMP cyclohydrolase from human CCRF-CEM leukemia cells: purification, pH dependence, and inhibitors.
Szabados E; Hindmarsh EJ; Phillips L; Duggleby RG; Christopherson RI
Biochemistry; 1994 Nov; 33(47):14237-45. PubMed ID: 7947835
[TBL] [Abstract][Full Text] [Related]
30. AICA-ribosiduria due to ATIC deficiency: Delineation of the phenotype with three novel cases, and long-term update on the first case.
Ramond F; Rio M; Héron B; Imbard A; Marie S; Billiemaz K; Denommé-Pichon AS; Kuentz P; Ceballos I; Piraud M; Vincent MF; Touraine R
J Inherit Metab Dis; 2020 Nov; 43(6):1254-1264. PubMed ID: 32557644
[TBL] [Abstract][Full Text] [Related]
31. Structure and functional relationships in human pur H.
Beardsley GP; Rayl EA; Gunn K; Moroson BA; Seow H; Anderson KS; Vergis J; Fleming K; Worland S; Condon B; Davies J
Adv Exp Med Biol; 1998; 431():221-6. PubMed ID: 9598063
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the de novo purine nucleotide pathway as a therapeutic strategy in mitochondrial myopathy.
Kimoloi S
Pharmacol Res; 2018 Dec; 138():37-42. PubMed ID: 30267763
[TBL] [Abstract][Full Text] [Related]
33. Targeting tumour proliferation with a small-molecule inhibitor of AICAR transformylase homodimerization.
Spurr IB; Birts CN; Cuda F; Benkovic SJ; Blaydes JP; Tavassoli A
Chembiochem; 2012 Jul; 13(11):1628-34. PubMed ID: 22764122
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia drives the assembly of the multienzyme purinosome complex.
Doigneaux C; Pedley AM; Mistry IN; Papayova M; Benkovic SJ; Tavassoli A
J Biol Chem; 2020 Jul; 295(28):9551-9566. PubMed ID: 32439803
[TBL] [Abstract][Full Text] [Related]
35. AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
Marie S; Heron B; Bitoun P; Timmerman T; Van Den Berghe G; Vincent MF
Am J Hum Genet; 2004 Jun; 74(6):1276-81. PubMed ID: 15114530
[TBL] [Abstract][Full Text] [Related]
36. Identification of ATIC as a Novel Target for Chemoradiosensitization.
Liu X; Paila UD; Teraoka SN; Wright JA; Huang X; Quinlan AR; Gatti RA; Concannon P
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):162-173. PubMed ID: 29029884
[TBL] [Abstract][Full Text] [Related]
37. ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.
Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
[No Abstract] [Full Text] [Related]
38. Substrate channelling by human IMP synthase.
Szabados E; Wilson PK; Christopherson RI
Adv Exp Med Biol; 1998; 431():241-4. PubMed ID: 9598067
[No Abstract] [Full Text] [Related]
39. AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization.
Asby DJ; Cuda F; Beyaert M; Houghton FD; Cagampang FR; Tavassoli A
Chem Biol; 2015 Jul; 22(7):838-48. PubMed ID: 26144885
[TBL] [Abstract][Full Text] [Related]
40. 5-Amino-4-Imidazolecarboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase Polymorphisms Affect the Susceptibility to Multiple Myeloma.
Wang Y; Ling Z; Hu Z; Gui Y; Huang C; Yao Y; Li R
Lab Med; 2022 Sep; 53(5):465-474. PubMed ID: 35397004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
